Find clinical trials for Adenocarcinoma in Houston, TX
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Adenocarcinoma trials near Houston, TX, USA:
The purpose of this study is to evaluate the safety and efficacy of an investigational RAS(ON) inhibitor administered as monotherapy or in combinatio...
Phase 3
Houston, Texas, United States and 19 other locations
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard of care (SOC) observation only.
Phase 3
Houston, Texas, United States and 59 other locations
with neoadjuvant chemotherapy for the treatment of treatment-naïve subjects with borderline resectable and locally advanced pancreatic ductal adenocarcinoma...
Phase 1
Houston, Texas, United States and 5 other locations
of multi-dose dendritic cell (DC) therapy for pancreatic ductal adenocarcinoma (PDAC) including adenosquamous carcinoma administered after s...
Phase 1
Houston, Texas, United States and 2 other locations
The purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compared with SOC GnP alone.
Phase 3
Webster, Texas, United States and 32 other locations
participants to treat locally advanced unresectable or metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma (mGEA).T...
Phase 2
Houston, Texas, United States and 48 other locations
This study has stopped recruitment.Adults with advanced pancreatic cancer participate in this study. The study tests a type of immunotherapy. It is a...
Phase 1
Houston, Texas, United States and 20 other locations
The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitab...
Phase 3
Houston, Texas, United States and 118 other locations
cancer Trial Phase: Phase II Clinical Indication: Pancreatic ductal adenocarcinoma; Adenocarcinoma; AJCC I, II, or III; 1st Line ne...
Phase 2
Houston, Texas, United States and 2 other locations
unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma trial is to compare OS between cadonilimab combined with...
Phase 3
Houston, Texas, United States and 24 other locations
Clinical trials
Research sites
Resources
Legal